Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4
3(42.9%)
Early Phase 1
1(14.3%)
N/A
1(14.3%)
Phase 2
1(14.3%)
Phase 3
1(14.3%)
7Total
Phase 4(3)
Early Phase 1(1)
N/A(1)
Phase 2(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT07450365Phase 4Not Yet Recruiting

Evaluation of Long-term Efficacy of 4 to 6-month Course Antiviral Therapy for Neurodevelopmental Impairments Caused by Congenital Cytomegalovirus Infection

Role: collaborator

NCT07294027Not ApplicableNot Yet Recruiting

ICSI Versus Conventional IVF in Couples With Unexplained Infertility

Role: collaborator

NCT05737303Phase 3Recruiting

Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer

Role: collaborator

NCT06713655Not Yet Recruiting

Predicting Treatment Failure in HSIL Patients with Positive Margins After Conization Via Detection of PAX1 Methylation

Role: collaborator

NCT06472232Phase 4Not Yet Recruiting

Multicenter Study of Chloroprocaine Versus Ropivacaine for Epidural Labor Analgesia

Role: collaborator

NCT05578456Phase 4Not Yet Recruiting

Effect of Prednisone and Aspirin on IVF-ET Outcome Among Patients With Thyroid Autoimmunity

Role: collaborator

NCT05151016Early Phase 1Unknown

Long-term Use of Mifepristone in the Treatment of Adenomyosis

Role: collaborator

NCT03520439Phase 2Completed

Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis

Role: collaborator

NCT03217656Recruiting

The Jiaxing Birth Cohort in China

Role: collaborator

All 9 trials loaded